Biktarvy, formally known as biktarvy, represents a potent single-tablet regimen for treating HIV infection. This drug unites three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to multiply within the body, considerably lowering the viral load. For many individuals, B